ImmunologybioRxivPreprint
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
A. Addetia, L. Piccoli, J. B. Case…·Fran
The paper shows that cross-reactive antibodies, like S309, retain effector functions against emerging Omicron variants despite reduced neutralization.
DOI 10.1101/2023.01.17.523798